tiprankstipranks
Trending News
More News >
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market

FibroBiologics, Inc. (FBLG) Income Statement

Compare
215 Followers

FibroBiologics, Inc. Income Statement

Last quarter (Q3 2025), FibroBiologics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, FibroBiologics, Inc.'s net income was $-5.78M. See FibroBiologics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 13.74M$ 8.89M$ 4.47M$ 1.58M$ 1.17M
Depreciation and Amortization
$ 573.00K$ 437.00K$ 94.00K$ 0.00$ 1.17M
EBITDA
$ -10.57M$ -15.90M$ -4.37M$ -1.58M$ 0.00
Operating Income
$ -13.74M$ -8.89M$ -4.47M$ -1.58M$ -1.17M
Other Income/Expenses
$ 2.58M$ -7.60M$ -654.00K$ -4.00K$ 0.00
Pretax Income
$ -11.16M$ -16.48M$ -5.12M$ -1.58M$ -1.17M
Net Income
$ -11.16M$ -16.48M$ -5.12M$ -1.58M$ -1.17M
Per Share Metrics
Basic EPS
$ -0.34$ -0.59$ -0.16$ -0.05$ -0.04
Diluted EPS
$ -0.34$ -0.59$ -0.16$ -0.05$ -0.04
Weighted Average Shares Outstanding
32.88M 32.49M 32.48M 32.48M 32.49M
Weighted Average Shares Outstanding (Diluted)
32.88M 32.49M 32.48M 32.48M 32.49M
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History